发布求助
文献互助 智能选刊 最新文献

B45. COPD: TREATMENT最新文献

筛选
英文 中文
Inhaled Corticosteroids Dose Regimens: Therapeutic Relevance of Lipophilicity, Solubility, Dissolution and Absorption from the Lung 吸入皮质类固醇剂量方案:亲脂性、溶解度、溶出度和肺吸收的治疗相关性
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3331
P. Daley-Yates
{"title":"Inhaled Corticosteroids Dose Regimens: Therapeutic Relevance of Lipophilicity, Solubility, Dissolution and Absorption from the Lung","authors":"P. Daley-Yates","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3331","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3331","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116906472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Tolerance and Safety of Humidified High-Flow Nasal Cannula Oxygen Therapy in Patients Hospitalized with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) 湿化高流量鼻插管氧疗在慢性阻塞性肺疾病(COPD)急性加重期住院患者中的耐受性和安全性
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3327
A. Pandya, G. Criner, J. So, M. Jacobs, J. Thomas, H. Criner
{"title":"Tolerance and Safety of Humidified High-Flow Nasal Cannula Oxygen Therapy in Patients Hospitalized with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)","authors":"A. Pandya, G. Criner, J. So, M. Jacobs, J. Thomas, H. Criner","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3327","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3327","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127360181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
DT-0111: A Novel Therapeutic Approach for COPD and Chronic Cough DT-0111:一种治疗COPD和慢性咳嗽的新方法
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3307
A. Pelleg, B. Undem, F. Xu
{"title":"DT-0111: A Novel Therapeutic Approach for COPD and Chronic Cough","authors":"A. Pelleg, B. Undem, F. Xu","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3307","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3307","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121908758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Pharma Management of COPD in Primary Care: Guideline Implementation a Continuing Challenge 初级保健中COPD的非药物管理:指南的实施是一个持续的挑战
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3338
R. Angus, L. Davies, E. Mcknight, P. England, K. Sheridan, K. Sargeant, M. Pearson
{"title":"Non-Pharma Management of COPD in Primary Care: Guideline Implementation a Continuing Challenge","authors":"R. Angus, L. Davies, E. Mcknight, P. England, K. Sheridan, K. Sargeant, M. Pearson","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3338","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3338","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125526962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Endoscopic Lung Volume Reductions in Patients with Severe Emphysema - Single Center Experience 内镜下肺体积减小对严重肺气肿患者的影响-单中心经验
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3332
M. Brutsche, T. Schneider, K. Kozu, L. Kern, F. Baty
{"title":"Effect of Endoscopic Lung Volume Reductions in Patients with Severe Emphysema - Single Center Experience","authors":"M. Brutsche, T. Schneider, K. Kozu, L. Kern, F. Baty","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3332","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3332","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"6 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129488508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Revefenacin for Nebulization in Patients with Chronic Obstructive Pulmonary Disease Taking Concomitant LABA or ICS/LABA 慢性阻塞性肺疾病患者同时服用LABA或ICS/LABA雾化治疗利芬酸的安全性和有效性
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3318
S. Sethi, J. Donohue, G. Ferguson, C. Barnes, G. Crater
{"title":"Safety and Efficacy of Revefenacin for Nebulization in Patients with Chronic Obstructive Pulmonary Disease Taking Concomitant LABA or ICS/LABA","authors":"S. Sethi, J. Donohue, G. Ferguson, C. Barnes, G. Crater","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3318","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3318","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130621070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy of Once-Daily Umeclidinium and Twice-Daily Salmeterol in Symptomatic Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: Results from the EMAX Trial 每日一次乌莫克利地铵和每日两次沙美特罗在无吸入皮质类固醇的慢性阻塞性肺疾病症状患者中的比较疗效:EMAX试验的结果
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3320
E. Kerwin, C. Vogelmeier, L. Bjermer, F. Maltais, M. Watkins, L. Tombs, I. Naya, I. Boucot, David A. Lipson, C. Compton, P. Jones
{"title":"Comparative Efficacy of Once-Daily Umeclidinium and Twice-Daily Salmeterol in Symptomatic Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: Results from the EMAX Trial","authors":"E. Kerwin, C. Vogelmeier, L. Bjermer, F. Maltais, M. Watkins, L. Tombs, I. Naya, I. Boucot, David A. Lipson, C. Compton, P. Jones","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3320","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3320","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"221 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132237357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Improves Lung Function in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies 甘罗酸/富马酸福莫特罗计量吸入器(GFF MDI)改善GOLD A类COPD患者的肺功能:来自PINNACLE III期研究的汇总数据
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3345
F. J. Martinez, K. Rabe, B. Lipworth, S. Arora, M. Jenkins, A. Maes, U. Martin, C. Reisner
{"title":"Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Improves Lung Function in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies","authors":"F. J. Martinez, K. Rabe, B. Lipworth, S. Arora, M. Jenkins, A. Maes, U. Martin, C. Reisner","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3345","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3345","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"77 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129183360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results on Rescue Use and Night-Time Awakenings IMPACT试验:单吸入器三合一治疗糠酸氟替卡松/乌莫列地铵/维兰特罗与糠酸氟替卡松/维兰特罗和乌莫列地铵/维兰特罗对COPD患者的影响:抢救使用和夜间觉醒的结果
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3347
M. Kaisermann, G. Criner, M. Dransfield, D. Halpin, M. Han, C. E. Jones, S. Kilbride, P. Lange, D. Lomas, F. Martinez, S. Pascoe, D. Singh, R. Wise, David A. Lipson
{"title":"The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results on Rescue Use and Night-Time Awakenings","authors":"M. Kaisermann, G. Criner, M. Dransfield, D. Halpin, M. Han, C. E. Jones, S. Kilbride, P. Lange, D. Lomas, F. Martinez, S. Pascoe, D. Singh, R. Wise, David A. Lipson","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3347","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3347","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124052088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Inhaled Umeclidinium/Vilanterol in COPD According to Level of Airflow Limitation: A Post Hoc Analysis 根据气流限制水平吸入乌莫替尼/维兰特罗治疗COPD的疗效和安全性:事后分析
B45. COPD: TREATMENT Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3330
M. Asmus, L. Tombs, Riju Ray, I. Naya, I. Boucot
{"title":"Efficacy and Safety of Inhaled Umeclidinium/Vilanterol in COPD According to Level of Airflow Limitation: A Post Hoc Analysis","authors":"M. Asmus, L. Tombs, Riju Ray, I. Naya, I. Boucot","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3330","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3330","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"15 7-8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116750177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信